US FDA cites Shire and Genentech for misleading promotions
This article was originally published in Scrip
Executive Summary
The US FDA has cited Shire Pharmaceuticals and Roche's Genentech unit for making false or misleading promotional claims about their drugs in professional materials for physicians.